| pubmed-article:17687836 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17687836 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17687836 | lifeskim:mentions | umls-concept:C0282540 | lld:lifeskim |
| pubmed-article:17687836 | lifeskim:mentions | umls-concept:C0543891 | lld:lifeskim |
| pubmed-article:17687836 | lifeskim:mentions | umls-concept:C0459435 | lld:lifeskim |
| pubmed-article:17687836 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17687836 | pubmed:dateCreated | 2007-8-10 | lld:pubmed |
| pubmed-article:17687836 | pubmed:abstractText | We carried out a retrospective descriptive study to determine prevalence and risk factors for tardive dyskinesia (TD) among psychotic patients treated with conventional neuroleptics in 4 centres in Saudi Arabia. Records of patients who had been taking > or = 1 conventional neuroleptic for > or = 6 months from January 1997 to December 2000 were examined; 151 patients were included in the final analysis. Only 51 had TD; another 59 (6.8%) patients had drug-induced Parkinson disease. Duration of treatment (P < 0.001), higher doses of neuroleptics (P < 0.01) and age over 40 years (P < 0.01) were associated with TD. A statistically significant difference in prevalence was found between Arabs (23.5%) and Afro-Arabs (45.5%) (P < 0.01). Overall prevalence of TD among psychotic patients was 5.9%. | lld:pubmed |
| pubmed-article:17687836 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17687836 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17687836 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17687836 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17687836 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17687836 | pubmed:issn | 1020-3397 | lld:pubmed |
| pubmed-article:17687836 | pubmed:author | pubmed-author:OsmanAA | lld:pubmed |
| pubmed-article:17687836 | pubmed:author | pubmed-author:MarghalaniMM | lld:pubmed |
| pubmed-article:17687836 | pubmed:author | pubmed-author:TurkistaniI... | lld:pubmed |
| pubmed-article:17687836 | pubmed:author | pubmed-author:Al-SwafMM | lld:pubmed |
| pubmed-article:17687836 | pubmed:author | pubmed-author:Bin SadiqBB | lld:pubmed |
| pubmed-article:17687836 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17687836 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:17687836 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17687836 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17687836 | pubmed:pagination | 625-32 | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:meshHeading | pubmed-meshheading:17687836... | lld:pubmed |
| pubmed-article:17687836 | pubmed:articleTitle | Neuroleptic-induced tardive dyskinesia among Arab psychotic patients. | lld:pubmed |
| pubmed-article:17687836 | pubmed:affiliation | Psychiatric Department, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia. akarimosman@yahoo.co.uk | lld:pubmed |
| pubmed-article:17687836 | pubmed:publicationType | Journal Article | lld:pubmed |
